Articles tagged "Elderly patients"

2019 American Transplant Congress
Lung Transplantation in the Elderly Patients with Multi-Comorbidities
N. Shigemura, Y. Toyoda
Temple University Health System / Lewis Katz School of Medicine, Philadelphia, PA
*Purpose: Recently there is an outstanding steadily increase in elderly patients above 70 years old who are referred to our center as potential candidates for…
2019 American Transplant Congress
Basiliximab versus T-cell Depleting Induction Therapy in Elderly Kidney Transplant Recipients
G. Vranic, H. Shah, B. Thomas, B. Javaid, J. Moore, M. Cooper, A. Gilbert
MedStar Georgetown Transplant Institute, Washington, DC
*Purpose: The ideal induction therapy for elderly kidney transplant recipients is not known. Given concerns about increased risk of infection and malignancy and perceived decreased…
2019 American Transplant Congress
Evaluating Potentially Inappropriate Prescribing in Older Kidney Transplant Recipients
L. DeVietro¹, B. Richardson², E. A. Cohen³, A. H. Toledo⁴, E. Marin⁵, K. R. Szempruch⁶
¹University of St. Joseph School of Pharmacy, Hartford, CT, ²University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, ³Pharmacy, Yale New Haven Hospital, New Haven, CT, ⁴Surgery-Transplant, University of North Carolina Medical Center, Chapel Hill, NC, ⁵Nephrology, Yale New Haven Hospital, New Haven, CT, ⁶Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC
*Purpose: While the Beers criteria (BC) and STOPP criteria (SC) have been validated in several patient populations to reduce medication use leading to adverse drug…
2019 American Transplant Congress
Is Alemtuzumab Induction Safe In Septuagenarians Undergoing Deceased Donor Kidney Transplantation?
D. Harriman, V. Gurram, C. Jay, J. Rogers, A. Farney, G. Orlando, A. Reeves-Daniel, A. Mena-Gutierrez, R. Stratta
Wake Forest Baptist Medical Center, Winston-Salem, NC
*Purpose: Alemtuzumab induction in septuagenarians is controversial but understudied.*Methods: Single center retrospective review of adult deceased donor kidney transplant (KT) recipients receiving single dose (30…
2019 American Transplant Congress
Economic Evaluation of Kidney Transplantation in the Elderly Stratified by Donor Quality
M. Kadatz¹, S. Klarenbach², J. S. Gill¹, J. Gill¹
¹Nephrology, University of British Columbia, Vancouver, BC, Canada, ²Nephrology, University of Alberta, Edmonton, AB, Canada
*Purpose: The cost-effectiveness of kidney transplantation in the elderly in recipients of a kidney with a high kidney donor profile index (KDPI) is unknown. In…
2019 American Transplant Congress
Clinical, Aging, Morphometric Measures & Adverse Outcomes in Kidney Transplant Recipients
A. Muzaale¹, N. Chu¹, H. Ying¹, B. Ross², D. Segev¹, M. McAdams-Demarco¹
¹JHU, Baltimore, MD, ²UM, Ann Habor, MI
*Purpose: Sarcopenia is a hallmark of frailty, a geriatric phenotype which is common among kidney transplant (KT) candidates and recipients. Sarcopenic-obesity is a high-risk state…
2019 American Transplant Congress
A Financial Analysis of Elderly Kidney Transplant Recipients
A. Yaldo, I. Bajjoka, C. Crombez, M. Abouljoud
Henry Ford Transplant Institute, Detroit, MI
*Purpose: To compare and evaluate outcomes of for younger (Y) versus elderly (E) kidney transplant recipients (KTR) during the first year post-transplant. As the number…
2019 American Transplant Congress
Everolimus/Low Tacrolimus Exposure versus Sodium Mycophenolate/Standard Tacrolimus for the Elderly Kidney Transplant Recipient. A 4-y Follow-Up of the nEverOld Trial
E. David-Neto, F. Agena, F. J. Paula, N. Z. Galante, D. S. David, F. Ramos, A. K. Triboni, P. Romano, P. A. Ebner, V. Coelho, M. Altona, R. Falci, A. Piovesan, W. C. Nahas
Renal Transplantation Service, Hospital das Clínicas - University of São Paulo School of Medicine, Sao Paulo, Brazil
*Purpose: The standard immunosuppressive regimen used for younger patients may not be adequate for the elderly cohort.*Methods: The nEverOld is a prospective, single-center, randomized trial…
2019 American Transplant Congress
Whole Body CT Imaging in Deceased Donor Screening
J. W. Mensink¹, R. A. Pol.², W. N. Nijboer¹, J. de Jonge³, K. M. Ooms - de Vries⁴, M. F. van der Jagt⁵, M. C. van de Poll⁶, I. P. Alwayn¹, A. E. Braat¹
¹Department of Surgery; Division of Transplantation, Leiden University Medical Center, Leiden, Netherlands, ²Department of Surgery; Division of Transplantation, University Medical Center Groningen, Groningen, Netherlands, ³Department of Surgery; Division of Transplantation, Erasmus Medical Center, Rotterdam, Netherlands, ⁴Dutch Transplant Foundation, Leiden, Netherlands, ⁵Department of Surgery; Division of Transplantation, University Medical Center St. Radboud, Nijmegen, Netherlands, ⁶Department of Surgery and Department of Intensive Care, Maastricht University Medical Center, Maastricht, Netherlands
*Purpose: Using older (extended criteria) donors to increase the donor pool increases the risk of malignancies in the donor. Our aim was to analyze the…
2019 American Transplant Congress
Liver Transplant Outcomes in Patients with Atrial Fibrillation
D. Devuni¹, P. Mahboub², P. Martins², C. Barry¹, I. Zacharias¹, B. Movahedi², G. Barnard¹, A. Bozorgzadeh²
¹Division of Gastroenterology, University of Massachusetts Medical School, Worcester, MA, ²Surgery, Division of Transplantation, University of Massachusetts Medical School, Worcester, MA
*Purpose: There is an increase in percentage of patients over the age of 65 yrs. who are being listed for liver transplantation (LT). Patients with…

« Previous Page
1
…
6
7
8
9
10
…
17
Next Page »